Riskpilot← Back to searchSign inGet full accessDANISH BIOTECH SPV I P/S
KASIn liquidationCVR 30274040Axeltorv 2Ikke-finansielle holdingselskaber · NACE 642020Est. 2007— employees
Revenue 2021
DKK -25K
-19% vs 2020
EBITDA margin
100.0%
+19% vs 2020
Equity ratio
48.2%
Financial strength
Net profit 2021
DKK 94K
+391% vs 2020
| Revenue | DKK -25K | -19% |
| EBITDA | DKK -25K | +19% |
| Net profit | DKK 94K | +391% |
| Total assets | DKK 94K | +162% |
| Equity | DKK 45K | +193% |
| Employees | — | — |
Legal name
DANISH BIOTECH SPV I P/S
CVR number
30274040
Legal form
Kommanditaktieselskab/Partnerselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
13. februar 2007
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af likvidator
Address
Axeltorv 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | -65 | -39 | -54 | -31 | -25 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -65 | -39 | -54 | -31 | -25 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -65 | -39 | -54 | -31 | -25 |
| Net financials | -1.601 | -15.170 | -523 | -1 | 120 |
| Profit before tax | -1.666 | -15.209 | -577 | -32 | 94 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.666 | -15.209 | -577 | -32 | 94 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 16.320 | 611 | 27 | 36 | 94 |
| Equity | -4.563 | 560 | -17 | -49 | 45 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 20.883 | 51 | 44 | 85 | 49 |
| Total debt | 20.883 | 51 | 44 | 85 | 49 |
EBITDA margin
-2533900.0%
This company
15.8%
Market median
-16037442% vs market
20172021
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20172021
Return on equity
207.9%
This company
18.4%
Market median
+1030% vs market
20172021
Net profit margin
9423900.0%
This company
8.1%
Market median
+116344344% vs market
20172021
Asset turnover
-0.27×
This company
1.12×
Market median
-124% vs market
20172021
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (10) | ||
JP Management | Management | 2007 – 2007 |
SL Chief Executive Officer | Chief Executive Officer | 2007 – 2007 |
OF General Partner | General Partner | 2007 – 2007 |
SF Unofficial title | Unofficial title | 2020 – 2022 |
JJ Management | Management | 2007 – 2007 |
OF Stakeholder | Stakeholder | 2007 – 2007 |
KA Management | Management | 2019 – 2020 |
DB General Partner | General Partner | 2007 – 2022 |
KA Chief Executive Officer | Chief Executive Officer | 2017 – 2018 |
MD Management | Management | 2017 – 2017 |
| Name | Role | Member since |
|---|---|---|
| Former (10) | ||
| Board of Directors | 2007 – 2007 | |
| Chairman | 2007 – 2007 | |
| Chairman | 2014 – 2015 | |
| Chairman | 2007 – 2011 | |
| Chairman | 2011 – 2014 | |
| Chairman | 2019 – 2020 | |
| Chairman | 2019 – 2019 | |
| Chairman | 2015 – 2016 | |
| Board of Directors | 2007 – 2018 | |
| Board of Directors | 2019 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DANISH BIOTECH SPV I P/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Peter Luff | Management | 0 companies |
| Steen Lønberg Jørgensen | Chief Executive Officer | 0 companies |
| Omega Fund Management | General Partner | 0 companies |
| Søren Fogh | Unofficial title | 0 companies |
| Julie Jones | Management | 0 companies |
| Omega Fund Management | Stakeholder | 0 companies |
| Kris Allen | Management | 0 companies |
| DANISH BIOTECH SPV I GP LIMITED | General Partner | 0 companies |
| Kris Allen | Chief Executive Officer | 0 companies |
| Martin David Mullins | Management | 0 companies |
| Lars Dybkjær | Board of Directors | 0 companies |
| Søren Møller Nielsen | Chairman | 0 companies |
| Sharon Rose Alvarez-Masterton | Chairman | 0 companies |
| Constance Adele Elisabeth Helyar | Chairman | 0 companies |
| Kevin Lionel Brennan | Chairman | 0 companies |
| John Nathan Bishop | Chairman | 0 companies |
| James Nicolle | Chairman | 0 companies |
| David Nicholas Charles Bolton | Chairman | 0 companies |
| Barry Gerald Mc Clay | Board of Directors | 0 companies |
| Sarah Macknight | Board of Directors | 0 companies |